With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon
New York Times
Apr 22, 2021
Dr. Matthew Wynia, Director of the Center for Bioethics and Humanities, said that health officials faced a frightening trade-off in choosing between a pause and warning: They would know only hypothetically the lives a pause may have cost, but they would know exactly who may have suffered or died from clots. Read article>>
